2299P Access to oncology drugs in the UK are we falling behind Europe after Brexit? A retrospective analysis of regulatory performance and reimbursement for oncology drugs in the UK and Europe (2021-2025)
Khanna, S., Sullivan, R., Lee, R., Krell, J., Jenei, K., Benjamin, D., Savage, P. & Lythgoe, M.
(2025).
2299P Access to oncology drugs in the UK are we falling behind Europe after Brexit? A retrospective analysis of regulatory performance and reimbursement for oncology drugs in the UK and Europe (2021-2025).
Annals of Oncology,
36(Supplement 2), S1264.
https://doi.org/10.1016/j.annonc.2025.08.2915
| Item Type | Article |
|---|---|
| Copyright holders | © 2025 Published by Elsevier Ltd |
| Departments | LSE > Academic Departments > Health Policy |
| DOI | 10.1016/j.annonc.2025.08.2915 |
| Date Deposited | 12 Nov 2025 |
| URI | https://researchonline.lse.ac.uk/id/eprint/130128 |